Dr. Adam S. Asch
Claim this profileUniversity of Oklahoma Health Sciences Center
Studies T-Lymphoblastic Leukemia/Lymphoma
Studies Myeloid Leukemia
15 reported clinical trials
29 drugs studied
Area of expertise
1T-Lymphoblastic Leukemia/Lymphoma
CD5 positive
CD19 positive
Stage I
2Myeloid Leukemia
t(8;21) negative
inv(16) negative
t(16;16) negative
Affiliated Hospitals
Clinical Trials Adam S. Asch is currently running
JCAR017
for Chronic Leukemia or Lymphoma
This trial tests JCAR017, a therapy using modified immune cells, in adults with hard-to-treat CLL or SLL. It aims to see if these enhanced immune cells can better fight the cancer.
Recruiting1 award Phase 1 & 2
Nivolumab + Cabozantinib
for Melanoma
This trial tests if nivolumab and cabozantinib can help patients with mucosal melanoma. Nivolumab boosts the immune system, while cabozantinib stops cancer cells from growing. The goal is to prevent the cancer from coming back or spreading. Nivolumab and cabozantinib have shown efficacy in treating various cancers, including melanoma and renal cell carcinoma.
Recruiting0 awards Phase 2
More about Adam S. Asch
Clinical Trial Related6 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Adam S. Asch has experience with
- Nivolumab
- Cytarabine
- Venetoclax
- Ibrutinib
- Daunorubicin
- ADP-A2M4CD8
Breakdown of trials Adam S. Asch has run
T-Lymphoblastic Leukemia/Lymphoma
Myeloid Leukemia
Acute Myeloid Leukemia
Lymphoid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Adam S. Asch specialize in?
Adam S. Asch focuses on T-Lymphoblastic Leukemia/Lymphoma and Myeloid Leukemia. In particular, much of their work with T-Lymphoblastic Leukemia/Lymphoma has involved CD5 positive patients, or patients who are CD19 positive.
Is Adam S. Asch currently recruiting for clinical trials?
Yes, Adam S. Asch is currently recruiting for 3 clinical trials in Oklahoma City Oklahoma. If you're interested in participating, you should apply.
Are there any treatments that Adam S. Asch has studied deeply?
Yes, Adam S. Asch has studied treatments such as Nivolumab, Cytarabine, Venetoclax.
What is the best way to schedule an appointment with Adam S. Asch?
Apply for one of the trials that Adam S. Asch is conducting.
What is the office address of Adam S. Asch?
The office of Adam S. Asch is located at: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104 United States. This is the address for their practice at the University of Oklahoma Health Sciences Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.